lLong-Term Outcomes after Proton Therapy, with Concurrent Chemotherapy, for Stage II-III Inoperable Non-Small Cell Lung Cancer
暂无分享,去创建一个
Joe Y. Chang | Z. Liao | L. Levy | J. Cox | R. Mehran | M. Gillin | P. Allen | Charles Lu | Q. Nguyen | R. Komaki | R. Daniel | N. Ly | Gómez | J. Cox
[1] M. Parmar,et al. Postoperative radiotherapy for non-small cell lung cancer. , 2016, The Cochrane database of systematic reviews.
[2] W. Curran,et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. , 2015, The Lancet. Oncology.
[3] T. Hashimoto,et al. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer. , 2014, Clinical lung cancer.
[4] C. Dooms,et al. Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] J. Slater,et al. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center. , 2013, International journal of radiation oncology, biology, physics.
[6] Zuofeng Li,et al. Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results. , 2012, Clinical lung cancer.
[7] Radhe Mohan,et al. Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration , 2012, Physics in medicine and biology.
[8] J. Cox. Are the results of RTOG 0617 mysterious? , 2012, International journal of radiation oncology, biology, physics.
[9] Benjamin Movsas,et al. Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. , 2012, International journal of radiation oncology, biology, physics.
[10] H. Satoh,et al. Proton beam therapy of Stage II and III non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.
[11] Joe Y. Chang,et al. Phase 2 study of high‐dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer , 2011, Cancer.
[12] C. Lawton. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117 , 2011 .
[13] M. Socinski,et al. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] George Starkschall,et al. Image-guided radiation therapy for non-small cell lung cancer. , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[15] Brady T. West,et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[16] C. Ling,et al. Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma , 2005, Cancer.
[17] M. Socinski,et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] S. Burdett,et al. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.